中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

48 records (took 0.024 seconds)

    THRESHOLD BASED AUTOMATIC GLUCOSE CONTROL RESPONSE
    12.
    发明申请
    THRESHOLD BASED AUTOMATIC GLUCOSE CONTROL RESPONSE 有权

    公开(公告)号：US20220379029A1

    公开(公告)日：2022-12-01

    申请号：US17824494

    申请日：2022-05-25

    Applicant: Insulet Corporation

    Inventor： Ashutosh ZADE ,  Joon Bok LEE ,  Yibin ZHENG

    IPC: A61M5/172 ,  G16H20/17 ,  A61B5/145 ,  A61B5/00 ,  G16H40/63 ,  A61M5/142

    Abstract: Provided is a wearable medical device that includes a processor or logic circuitry. The wearable medical device may include a memory storing instructions that, when executed by the processor or logic circuitry, configure the wearable medical device to determine, by the processor or the logic circuitry, that an event affecting a blood glucose measurement value trend of a user has occurred. Based on the occurrence of the event, the processor or the logic circuitry may select a mode of operation of the analyte sensor, and generate a signal indicating the selected mode of operation. The mode of operation may correspond to a sampling frequency of a physical attribute or physiological condition of a user of the wearable medical device.

    DEVICES AND METHODS FOR INITIALIZATION OF DRUG DELIVERY DEVICES USING MEASURED ANALYTE SENSOR INFORMATION
    13.
    发明申请
    DEVICES AND METHODS FOR INITIALIZATION OF DRUG DELIVERY DEVICES USING MEASURED ANALYTE SENSOR INFORMATION 有权

    公开(公告)号：US20220347386A1

    公开(公告)日：2022-11-03

    申请号：US17730839

    申请日：2022-04-27

    Applicant: Insulet Corporation

    Inventor： Ashutosh ZADE ,  Joon Bok LEE ,  Yibin ZHENG

    IPC: A61M5/172 ,  G16H20/13 ,  G16H20/17 ,  G16H40/67

    Abstract: Disclosed are processes and techniques implementable by a drug delivery system to maintain optimal drug delivery for a patient according to a treatment plan. The disclosed techniques enable a new drug delivery device that is exchanged for a previous drug delivery device to operate using analyte-based drug delivery control immediately during initialization instead of having to wait for a warm-up period. For example, a drug delivery device may include a processor and a memory storing instructions that, when executed by the processor, operate the drug delivery device to receive a present analyte measurement value from an analyte sensor during an initialization of the drug delivery device, receive backfill values measured by the analyte sensor prior to the initialization, calculate a dosage of a drug using the present analyte measurement value and the backfill values, and deliver the dosage of the drug. Other embodiments are described.

    INCORPORATION OF ADDITIONAL SENSORS INTO ADAPTATION OF AID SYSTEMS
    16.
    发明公开
    INCORPORATION OF ADDITIONAL SENSORS INTO ADAPTATION OF AID SYSTEMS 审中-公开

    公开(公告)号：US20240100253A1

    公开(公告)日：2024-03-28

    申请号：US18466211

    申请日：2023-09-13

    Applicant: INSULET CORPORATION

    Inventor： Joon Bok LEE ,  Yibin ZHENG ,  Jason O'CONNOR ,  Ashutosh ZADE

    IPC: A61M5/172 ,  A61M5/142

    CPC classification number: A61M5/1723 ,  A61M5/14244 ,  A61M2202/0486 ,  A61M2230/04 ,  A61M2230/40

    Abstract: Disclosed are techniques, devices and systems that provide adjustments to parameter settings of an insulin delivery algorithm based on inputs from a number of generic sensor devices. A majority of the generic sensor devices provide sensor readings that are unused as inputs to a drug deliver algorithm. The generic sensor devices may be operable to detect characteristics, such as changes in a state of a user. A processor may evaluate a sensor reading provided by a particular sensor with respect to a sensor baseline reading for the particular sensor. Using the result of the evaluation, the processor may calculate an adjustment to a parameter setting or settings of a medication delivery algorithm. A dosage of medication may be modified based on the adjustment of the parameter setting or settings.

    SAFETY AND ACCURACY MEASURES FOR MEDICAMENT BOLUS DELIVERY
    17.
    发明公开
    SAFETY AND ACCURACY MEASURES FOR MEDICAMENT BOLUS DELIVERY 审中-公开

    公开(公告)号：US20240075214A1

    公开(公告)日：2024-03-07

    申请号：US18450238

    申请日：2023-08-15

    Applicant: INSULET CORPORATION

    Inventor： Ashutosh ZADE ,  Joon Bok LEE ,  Yibin ZHENG ,  Rangarajan NARAYANASWAMI ,  Jason O’CONNOR

    IPC: A61M5/315 ,  G16H20/17

    CPC classification number: A61M5/31566 ,  G16H20/17

    Abstract: Safety and accuracy measures may be provided in a medicament delivery device. The medicament delivery device may be able to identify the inadvertent delivery of duplicate medicament boluses by a user. The exemplary embodiments may set limits for maximum allowable medicament bolus doses and maximum cumulative bolus doses over an interval. The exemplary embodiments may provide automatic meal detection and may use detection of meals in determining whether a user-requested medicament bolus dose should be adjusted or rejected. The exemplary embodiments may facilitate delivery of partial boluses and the delivery of remainders of the boluses contingent on acceptable glucose level trends of the user. The exemplary embodiments may resolve potential conflicts among multiple medicament delivery devices via a broker or by providing a single actor, such as a medicament delivery controller, that has sole control of dosing and delivery of medicament boluses.

    TRANSITIONS TO REPLACEMENT ON-BODY MEDICAL DEVICES FROM EXPIRING ON-BODY MEDICAL DEVICES THAT AVOID DOWNTIME
    20.
    发明申请
    TRANSITIONS TO REPLACEMENT ON-BODY MEDICAL DEVICES FROM EXPIRING ON-BODY MEDICAL DEVICES THAT AVOID DOWNTIME 有权

    公开(公告)号：US20230001088A1

    公开(公告)日：2023-01-05

    申请号：US17848673

    申请日：2022-06-24

    Applicant: INSULET CORPORATION

    Inventor： Ashutosh ZADE ,  Yibin ZHENG ,  Joon Bok LEE ,  Jason O'CONNOR

    IPC: A61M5/172 ,  A61M5/142

    Abstract: The switchover between an expiring on-body medicament delivery device and a replacement on-body medicament is made to eliminate or significantly decrease the time where an on-body medicament delivery device is operational to deliver medicament to a user. The replacement on-body medicament device is attached to the user and prepped for operation while the expiring on-body medicament delivery device is still operational. The switchover between on-body sensors also may be improved. Methods for calibrating a replacement on-body sensor while the expiring on-body sensor is still operative are provided. The calibrating may be performed quickly so that there is no gap in operation between expiration of the expiring on-body sensor and full operation of the replacement on-body sensor.

Patent Agency Ranking